JD Supra Law

JANUARY 11, 2024

DexCom, Inc. Abbott Diabetes Care, Inc., DexCom and Abbott are competing manufacturers of continuous glucose monitoring systems. But an exception allowed either company to challenge a patent asserted. 2023-1795 (Fed. Opinion by Stoll, joined by Dyk and Hughes. By: Alston & Bird

Settlement 65

Settlement Patent Licensing Litigation 65

IP Watchdog

MARCH 9, 2022

It was a banner district court week, with 104 patent filings and 64 cases terminated, mostly file-and-settle non-practicing entity (NPE) litigation, and 26 Patent Trial and Appeal Board (PTAB) cases, including Nokia challenging NPE TQ Delta, LLC; Dexcom, Inc. filing against Abbot Diabetes Care Inc.;

IP 111

IP Patent Litigation Government 111

IP Law 360

AUGUST 4, 2021

Abbott Laboratories has taken medical products rival Dexcom Inc. patents held by the diabetes technology company for glucose monitoring systems that continuously track blood sugar levels. to court in an attempt to invalidate four U.K.

Patent 52

Patent Technology 52

Patently-O

MARCH 1, 2024

Retail Decisions, Inc., 2024) (Dexcom) Decision_2023001547_02-26-2024 DexCom is a leader in continuous glucose monitoring. March 4, 2024) (The Upper Deck Company) Decision_2022004158_02-29-2024. The PTAB relied on CyberSource Corp. 3d 1366 (Fed. 2011) (holding the claims that could be “performed in the human mind.

Invention 67

Invention Patent Art Marketing 67